Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 600 of 2026 entries
View as:

A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00081484 Org: User:
Start: 06/30/04 End: 03/31/06 Due: 03/31/07

A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00089479 Org: User:
Start: 08/31/02 End: 05/31/12 Due: 05/31/13

A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril

Phase: N/A Priority: Normal
NCT ID: NCT01398267 Org: User:
Start: 08/31/11 End: 10/31/12 Due: 10/31/13

MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02486952 Org: User:
Start: 08/31/05 End: 01/31/11 Due: 01/31/12

A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00002247 Org: User:
Start: - End: - Due: -

An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00949910 Org: User:
Start: 11/30/04 End: 04/30/09 Due: 04/30/10

A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status

Phase: N/A Priority: Normal
NCT ID: NCT02831842 Org: User:
Start: 06/09/16 End: 11/30/17 Due: 11/30/18

A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00865189 Org: User:
Start: 10/23/07 End: 03/23/16 Due: 03/23/17

A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis

Phase: N/A Priority: Normal
NCT ID: NCT02879981 Org: User:
Start: 11/10/16 End: 08/28/17 Due: 08/28/18

Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain Edema

Phase: N/A Priority: Normal
NCT ID: NCT05399550 Org: User:
Start: 06/22/22 End: 11/17/22 Due: 11/17/23

A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02484703 Org: User:
Start: 10/28/15 End: 08/03/16 Due: 08/03/17

A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00576199 Org: User:
Start: 02/29/08 End: 05/31/11 Due: 05/31/12

A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT02729896 Org: User:
Start: 11/09/16 End: 10/07/19 Due: 10/07/20

A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00531934 Org: User:
Start: 10/31/07 End: 08/31/10 Due: 08/31/11

A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02008227 Org: User:
Start: 03/11/14 End: 01/09/19 Due: 01/09/20

Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in Croatia

Phase: N/A Priority: Normal
NCT ID: NCT02625844 Org: User:
Start: 09/30/11 End: 08/31/12 Due: 08/31/13

A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00436241 Org: User:
Start: 03/31/07 End: 11/30/10 Due: 11/30/11

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT03653364 Org: User:
Start: 01/23/19 End: 04/03/23 Due: 04/03/24

The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE)

Phase: N/A Priority: Normal
NCT ID: NCT00483938 Org: User:
Start: 06/30/07 End: 05/31/10 Due: 05/31/11

A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01009424 Org: User:
Start: 10/31/09 End: 12/31/09 Due: 12/31/10

A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01130337 Org: User:
Start: 07/31/10 End: 06/30/14 Due: 06/30/15

A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06733298 Org: User:
Start: 01/08/25 End: 01/29/25 Due: 01/29/26

A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival

Phase: N/A Priority: Normal
NCT ID: NCT00461708 Org: User:
Start: 05/31/07 End: 11/30/10 Due: 11/30/11

A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06734117 Org: User:
Start: 11/15/21 End: 12/26/24 Due: 12/26/25

Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants

Phase: N/A Priority: Normal
NCT ID: NCT02536664 Org: User:
Start: 09/30/09 End: 06/30/14 Due: 06/30/15